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Conclusion

Abstract
Gingival defects can be treated in multiple ways. The current gold
standard is connective tissue graft (CTG) in order to treat Class I and
II Miller defects (Chambrone, 2008). One of the newer procedures is
the use of platelet-rich fibrin (PRF) therapy, which involves drawing
the patient’s own blood and forming a membrane to heal gingival
defects. This literature review looks at scholarly articles comparing
the use of PRF to CTG in healing clinical attachment loss (CAL) over
a period of 6 months and whether one is more effective than the other
in gaining CAL.

According to the current research, there is no statistically significant
evidence to suggest that PRF has a greater gain in CAL when
compared to CTG over a period of 6 months. Some studies show that
both PRF and CTG have statistically significant increases in CAL but
comparing the data between the two procedures does not yield enough
significant difference to definitively conclude that one procedure
provides more improvement than the other. However, some studies
have shown that PRF has superior immediate post-operative healing
compared to CTG. PRF also contains numerous growth factors that
promote accelerated healing as well, which means the risk of postoperative complications is decreased.

Introduction
Periodontitis, the disease of the gums surrounding the teeth in the oral
cavity, may lead to serious consequences if not treated appropriately. It
has also been linked to a variety of systemic diseases as well, including
Type II diabetes, osteoporosis, obesity, and many other conditions
(Amar, 2006).
The American Academy of Periodontology classifies the severity of
periodontitis through a variety of factors, one of which is clinical
attachment loss (CAL). Maintaining CAL may reduce the risk of gum and
bone recession, which are both possible indicators of periodontitis. When
a patient has multiple gum defects or severe gum recession, one of the
options for treatment is gum surgery. Some of the possible indications for
gum surgery include dentinal hypersensitivity, esthetics, and preventing
the progression of further recession. The risk of developing root caries
also increases with root exposure.
One common surgery is the gum graft in which tissue is taken from a
different source and grafted onto the area of recession. The current gold
standard for gum surgery is connective tissue graft (CTG) surgery and
the donor site is usually the hard palate. The difference between CTG
compared to other types of tissue graft is that CTG takes specifically
subepithelial tissue and leaves the epithelial tissue intact at the donor
site (Chambrone, 2008). This accelerates the healing process due to
leaving behind intact epithelium. CTG surgery is often used in
conjunction with a coronally advanced flap (CAF), in which a pedicle flap
is formed at the site of the recession and the connective tissue is placed
between the periosteum and the overlying pedicle flap. This provides
continued blood supply to the area.
One of the relatively newer innovations in gum surgeries is the use of
platelet-rich fibrin (PRF) therapy in conjunction with pedicle flap surgery.
This method has been shown to contain various growth factors, which
help promote cell proliferation and tissue regeneration. It is meant to be
replacing the connective tissue used in CTG in adjunct with CAF and
does not replace the need for a surgical flap. One of the reasons for
using PRF instead of CTG is the lack of a second donor site for tissue,
which could potentially cause less discomfort for the patient. Both
procedures are very similar, since both often require the need for a
surgical flap, and the major difference is the chosen material underlying
the tissue flap. PRF is becoming more widespread due to its promotion
of accelerated healing.
The current generation of PRF involves extracting blood from the
patient’s own body and collected in tubes without anticoagulants. The
blood is centrifuged immediately after collection. A fibrin clot forms in the
tube between the layer of red blood cells and plasma, and this yellow
clot is separated from the clotted blood cells. The clot is compressed into
a thin membrane that is a uniform thickness. The membrane is placed in
the area of the mucogingival defect and a pedicle flap is used to hold the
membrane in position to allow for maximum integration with the
surrounding tissue.
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Methods
The study of the use of platelet-rich fibrin (PRF) therapy compared to
connective tissue graft (CTG) surgery in terms of clinical attachment
level after 6 months was done through a review of the literature.

Discussion
One comprehensive systematic review compared the use of PRF in
various dental procedures and concluded that PRF compared to CTG
had no statistically significant differences, although both increased
periodontal values in general, including CAL (Miron, 2017). In multiple
clinical trials, researchers compared PRF and CTG after 6 months by
measuring multiple periodontal statistics, including CAL and most
showed significant improvement in CAL but the difference between the
two procedures was not statistically significant. One study came to the
conclusion that more layers of PRF had an effect on CAL value
(Culhaoglu, 2018).
A randomized clinical trial comparing PRF and CTG found similar results
when comparing postoperative statistics regarding CAL. However, this
study did conclude that PRF had decreased postoperative discomfort
when compared to CTG (Oncu, 2017). Another clinical trial measured
healing index (HI) for the participants as well, and they found significant
increases in HI for immediate postoperative values (Culhaoglu, 2018). A
different clinical trial compared HI between PRF and CTG and found
differences in favor of PRF after 1 week, but the interval diminishes after
that period of time (Mufti, 2017).

Because PRF is a relatively novel procedure when treating gingival
defects, there is a lack of studies comparing its effectiveness to CTG.
There are many clinical trials and single clinical case studies, as well as
split-mouth randomized studies. It was difficult to find systematic
reviews and meta-analyses comparing PRF to CTG together.
There was also a lot of conflicting research between the various
articles. The formation of the PRF membrane is not currently a
standardized process, and clinicians have varying protocol nuances.
Some of the variations include centrifuge time, types of centrifuges,
membrane thickness, membrane size, and amount of blood drawn.
Therefore, the resulting information taken from literature reviews may
not be as accurate than if the clinical procedure was standardized to
eliminate the margin of error and increase external validity.
In order to have a more definitive answer about the comparison
between PRF and CTG in terms of long term CAL changes, more
research needs to be conducted. Based off of current research, it
appears that PRF is a suitable alternative to CTG but there is not
enough evidence backing PRF as a superior treatment option.
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Abstract
Gingival defects can be treated in multiple ways. The current gold standard is connective tissue
graft (CTG) in order to treat Class I and II Miller defects (Chambrone, 2008). One of the newer
procedures is the use of platelet-rich fibrin (PRF) therapy, which involves drawing the patient’s
own blood and forming a membrane to heal gingival defects. This literature review looks at
scholarly articles comparing the use of PRF to CTG in healing clinical attachment loss (CAL) over
a period of 6 months and whether one is more effective than the other in gaining CAL.

PLATELET-RICH FIBRIN VS. CONNECTIVE TISSUE GRAFT

3

Introduction
According to data from the 2009 and 2010 National Health and Nutrition Examination
Survey (NHANES), over 47% of the adult population of the United States age 30 and over has
periodontal disease, which can be approximated to 64.7 million Americans. Periodontitis is a
disease of the gums surrounding the teeth in the oral cavity and may lead to serious
consequences if not treated appropriately. The most common reason for tooth loss in adults
over the age of 45 is periodontitis and has also been linked to a variety of systemic diseases as
well, including Type II diabetes, osteoporosis, obesity, and many other conditions (Amar, 2006).
The American Academy of Periodontology classifies the severity of periodontitis through
a variety of factors, one of which is clinical attachment loss (CAL) (Tonetti, 2018). The CAL is a
sign of how much attached gingiva is missing from its original height on the tooth and is usually
an indicator of active or previous history of periodontitis. When bone starts to recede, the
gingival tissue may follow, which is why maintaining CAL is important. Gum and bone recession
are both possible indicators of periodontitis.
Gum recession can result from multiple reasons, with periodontal disease being one of
the most common. The gum separating the teeth starts to pull away, revealing more of the
tooth’s root surface. Miller’s classification is one standardized way of measuring the severity of
gum recession. A Class I Miller defect is recession that has not extended to the mucogingival
junction (MGJ) yet, and a Class II is one that has extended to or beyond the MGJ without any
loss of bone or soft tissue (Akram, 2016).
When a patient has multiple gum defects or severe gum recession, one of the options
for treatment is gum surgery. Some of the possible indications for gum surgery include dentinal
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hypersensitivity, esthetics, and preventing the progression of further recession. The risk of
developing root caries also increases with root exposure.
One common surgery is the gum graft in which tissue is taken from a different source
and grafted onto the area of recession. Tissue can be taken from the patient’s own body from a
separate location or from a donor, such as a cadaver or animal tissue. The current gold
standard for gum surgery is connective tissue graft (CTG) surgery. This involves taking a piece of
tissue from the patient’s own body, and the donor site is usually the hard palate. The difference
between CTG compared to other types of tissue graft is that CTG takes specifically subepithelial
tissue and leaves the epithelial tissue intact at the donor site (Chambrone, 2008). This
accelerates the healing process due to leaving behind intact epithelium. CTG surgery is often
used in conjunction with a coronally advanced flap (CAF), in which a pedicle flap is formed at
the site of the recession and the connective tissue is placed between the periosteum and the
overlying pedicle flap. This provides continued blood supply to the area.
One of the relatively newer innovations in gum surgeries is the use of platelet-rich fibrin
(PRF) therapy in conjunction with the surgery. This process was the result of experimentation
with platelet-rich plasma (PRP), which was a technique used to isolate large amounts of
platelets from the blood and use them to aid in accelerating wound healing. One of the
limitations of PRP was the need to combine the resulting liquid with other biomaterials such as
bone graft particles, so PRF was developed as a means to have all healing factors in a solid state
of matter that was more manageable. The material could not have any anticoagulants to
prevent clotting before placement into the body and centrifuging specimens was the only way
to retrieve healing factors in a solid layer. The platelet clot has been shown to contain various
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growth factors, which help promote cell proliferation and tissue regeneration. PRF is becoming
increasingly widespread due to its promotion of accelerated healing. It is being used due to its
ability to potentially regenerate periodontal structures such as the periodontal ligament. The
growth factors in PRF have been shown to stimulate fibroblasts to differentiate at an increased
rate, therefore promoting regeneration of the PDL (Goel, 2018). The PRF material is most
commonly used in combination with surgery, similarly to CTG, with the most frequent being a
pedicle flap. It is meant to be replacing the connective tissue used in CTG in adjunct with CAF
and does not replace the need for a surgical flap. One of the reasons for using PRF instead of
CTG is the lack of a second donor site for tissue, which could potentially cause less discomfort
for the patient. The PRF procedure is also relatively easier compared to CTG since it requires
fewer steps. Both CTG and PRF procedures are very similar, since both often require the need
for a surgical flap, and the major difference is the chosen material underlying the tissue flap.
The current generation of PRF involves extracting blood from the patient’s own body
and collected in tubes without anticoagulants. The blood is centrifuged immediately after
collection. A fibrin clot forms in the tube between the layer of red blood cells and plasma, and
this yellow clot is separated from the clotted blood cells. The clot is compressed into a thin
membrane that is a uniform thickness. The membrane is placed in the area of the mucogingival
defect and a pedicle flap is used to hold the membrane in position to allow for maximum
integration with the surrounding tissue.
Methods
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The study of the use of platelet-rich fibrin (PRF) therapy compared to connective tissue
graft (CTG) surgery in terms of clinical attachment level after 6 months was done through a
review of the literature.
Discussion
One comprehensive systematic review compared the use of PRF in various dental
procedures. The researchers concluded that PRF compared to CTG had no statistically
significant differences, although both increased periodontal values in general, including CAL
(Miron, 2017). In one clinical trial, researchers compared PRF and CTG after 6 months by
measuring multiple periodontal statistics, including CAL. Both showed significant improvement
in CAL but the difference between the two procedures was not statistically significant (Mufti,
2017). A different clinical study had a similarly structured trial in which periodontal statistics
between PRF and CTG were compared, and the researchers came to the conclusion that more
layers of PRF had an effect on CAL value, but the difference between the two procedures was
not statistically significant (Culhaoglu, 2018). Researchers in another split mouth randomized
controlled study studied the effects of PRF when used in conjunction with flap surgery. They
found that that there was a gain in CAL after 6 months and there was a statistically significant
difference between utilizing PRF and without it (Padma, 2013).
Researchers of a systematic review and meta-analysis studied the use of PRF in
randomized clinical trials with follow up periods of 6 months in the treatment of Miller Class I
and II gingival defects. The study concluded that the difference in CAL was not statistically
significant between the studied groups (Moraschini, 2016). One systematic review studied the
use of PRF in root coverage surgeries and found that most research was contradictory, but that
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PRF appears to have an advantage in regards to biotype and gingival tissue width. They did not
find any significant findings about CAL (Verma, 2017). A different systematic review solely
researched CTG and found that it was effective in increasing CAL, but did not produce any
significant difference when comparing CTG to other procedures, including surgeries with
resorbable membranes (Chambrone, 2008).
A randomized clinical trial comparing PRF and CTG found similar results when comparing
postoperative statistics regarding CAL. However, this study did conclude that PRF had
decreased postoperative discomfort when compared to CTG (Oncu, 2017). Another clinical trial
measured healing index (HI) for the participants as well, and they found significant increases in
HI for immediate postoperative values (Culhaoglu, 2018). A different clinical trial compared HI
between PRF and CTG and found differences in favor of PRF after 1 week, but the interval
diminishes after that period of time (Mufti, 2017).
Conclusion
According to the current research, there is no statistically significant evidence to suggest
that PRF has a greater gain in CAL when compared to CTG over a period of 6 months. There is
not enough evidence to suggest that PRF is superior to CTG in general when it comes to other
periodontal statistics as well. Some studies show that both PRF and CTG have statistically
significant increases in CAL but comparing the data between the two procedures does not yield
enough significant difference to definitively conclude that one procedure provides more
improvement than the other. However, some studies have shown that PRF has superior
immediate post-operative healing compared to CTG. This could be because PRF does not
require a second donor site for tissue like CTG does, which means one less site for the body to
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heal, resulting in decreased discomfort for the patient. PRF also contains numerous growth
factors that promote accelerated healing as well, which means the risk of post-operative
complications is decreased. PRF can also be an arguably simpler procedure than CTG since
there are fewer steps, and some patients may prefer shorter appointments.
Because PRF is a relatively novel procedure when treating gingival defects, there is a
lack of studies comparing its effectiveness to CTG. There are many clinical trials and single
clinical case studies, as well as split-mouth randomized studies. It was difficult to find
systematic reviews and meta-analyses comparing PRF to CTG together. There are multiple
journal articles that are systematic reviews of the procedures separately. There is also a lot
more research done on the application of PRF in other dental procedures, such as extraction
site healing and fixing intrabony defects.
There was also a lot of conflicting research between the various articles. The formation
of the PRF membrane is not currently a standardized process, and clinicians have varying
protocol nuances. Some of the variations include centrifuge time, types of centrifuges,
membrane thickness, membrane size, and amount of blood drawn. Therefore, the resulting
information taken from literature reviews may not be as accurate than if the clinical procedure
was standardized to eliminate the margin of error and increase external validity. Researchers
also studied different aspects of PRF in different trials. For example, one clinical trial compared
the effectiveness of varying amounts of PRF membrane layers and its effect on healing. Not
every study chose to measure CAL at the end of the clinical trials. Data on gingival biotype and
biological width was more frequently collected. The current research is also not standardized,
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and there was some variation amongst researchers on the way they measure CAL. Some studies
utilized a Marquis probe and others used marked acrylic stents.
In order to have a more definitive answer about the comparison between PRF and CTG
in terms of long-term CAL changes, more research needs to be conducted. Based on current
research, it appears that PRF is a suitable alternative to CTG but there is not enough evidence
backing PRF as a superior treatment option.
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